APOLs with low pH dependence can kill all African trypanosomes

Nature Microbiology

Volumn 2, Issue 11, 2017, Pages 1500-1506

  Fontaine, Frédéric ^a   Lecordier, Laurence ^a   Vanwalleghem, Gilles ^a,c   Uzureau, Pierrick ^a   Van Reet, Nick ^b   Fontaine, Martina ^a   Tebabi, Patricia ^a   Vanhollebeke, Benoit ^a   Büscher, Philippe ^b   Pérez Morga, David ^a   Pays, Etienne ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; RECOMBINANT APOLIPOPROTEIN 1; RECOMBINANT APOLIPOPROTEIN 3; UNCLASSIFIED DRUG; APOLIPOPROTEIN L; APOLIPOPROTEIN L1; PROTOZOAL PROTEIN; RECOMBINANT PROTEIN;

ACIDITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; MOUSE; MUTANT; NONHUMAN; PAPIO PAPIO; PH; PRIORITY JOURNAL; PROTEIN FUNCTION; TOXICITY; TRYPANOSOMA; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMA BRUCEI RHODESIENSE; TRYPANOSOMA CONGOLENSE; TRYPANOSOMA CRUZI; TRYPANOSOMA EVANSI; TRYPANOSOMA THEILERI; TRYPANOSOMA VIVAX; AFRICAN TRYPANOSOMIASIS; ANIMAL; DRUG EFFECT; GENETICS; METABOLISM; PARASITOLOGY; PHYSIOLOGY; TRYPANOSOMA BRUCEI BRUCEI;

ANIMALS; APOLIPOPROTEIN L1; APOLIPOPROTEINS L; HYDROGEN-ION CONCENTRATION; MICE; PAPIO PAPIO; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; TRYPANOSOMA; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMA BRUCEI RHODESIENSE; TRYPANOSOMA CONGOLENSE; TRYPANOSOMA VIVAX; TRYPANOSOMIASIS, AFRICAN;

EID: 85029584525     PISSN: None     EISSN: 20585276     Source Type: Journal    
DOI: 10.1038/s41564-017-0034-1     Document Type: Article

References (30)

1. Vanhollebeke, B. & Pays, E. The function of apolipoproteins L. Cell. Mol. Life Sci. 63, 1937-1944 (2006).
2. Hu, C. A., Klopfer, E. I. & Ray, P. E. Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease. FEBS Lett. 586, 947-955 (2012).
3. Pays, E., Vanhollebeke, B., Uzureau, P., Lecordier, L. & Pérez-Morga, D. The molecular arms race between African trypanosomes and humans. Nat. Rev. Microbiol. 12, 575-584 (2014).
4. Uzureau, S. et al. Apolipoproteins L control cell death triggered by TLR3/ TRIF signaling in dendritic cells. Eur. J. Immunol. 46, 1854-1866 (2016).
5. Vanhamme, L. et al. Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 422, 83-87 (2003).
6. Pérez-Morga, D. et al. Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science 309, 469-472 (2005).
7. Vanwalleghem, G. et al. Coupling of lysosomal and mitochondrial membrane permeabilization in trypanolysis by APOL1. Nat. Commun. 6, 8078 (2015).
8. Greene, A. S. & Hajduk, S. L. Trypanosome lytic factor-1 initiates oxidationstimulated osmotic lysis of Trypanosoma brucei brucei. J. Biol. Chem. 291, 3063-3075 (2016).
9. Shimamura, M., Hager, K. M. & Hajduk, S. L. The lysosomal targeting and intracellular metabolism of trypanosome lytic factor by Trypanosoma brucei brucei. Mol. Biochem. Parasitol. 115, 227-237 (2001).
10. Lecordier, L. et al. Identification of Trypanosoma brucei components involved in trypanolysis by normal human serum. Mol. Microbiol. 94, 625-636 (2014).
11. Thomson, R. & Finkelstein, A. Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: relevance to trypanosome lysis. Proc. Natl Acad. Sci. USA 112, 2894-2899 (2015).
12. Alsford, S., Currier, R. B., Guerra-Assunção, J. A., Clark, T. G. & Horn, D. Cathepsin-L can resist lysis by human serum in Trypanosoma brucei brucei. PLoS Pathog. 10, e1004130 (2014).
13. Xong, H. V. et al. A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense. Cell 95, 839-846 (1998).
14. Uzureau, P. et al. Mechanism of Trypanosoma gambiense resistance to human serum. Nature 501, 430-434 (2013).
15. Capewell, P. et al. The TgsGP gene is essential for resistance to human serum in Trypanosoma brucei gambiense. PLoS Pathog. 9, e1003686 (2013).
16. Lecordier, L. et al. C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. PLoS Pathog. 5, e1000685 (2009).
17. Genovese, G. et al. Association of trypanolytic apoL1 variants with kidney disease in African-Americans. Science 329, 841-845 (2010).
18. Thomson, R., Molina-Portela, P., Mott, H., Carrington, M. & Raper, J. Hydrodynamic gene delivery of baboon trypanosome lytic factor eliminates both animal and human-infective African trypanosomes. Proc. Natl Acad. Sci. USA 106, 19509-19514 (2009).
19. Page, N. M., Butlin, D. J., Lomthaisong, K. & Lowry, P. J. The human apolipoprotein L gene cluster: identification, classification, and sites of distribution. Genomics 74, 71-78 (2001).
20. Bruggeman, L. A. et al. Plasma apolipoprotein L1 levels do not correlate with CKD. J. Am. Soc. Nephrol. 25, 634-644 (2014).
21. Vanhollebeke, B., Lecordier, L., Perez-Morga, D., Amiguet-Vercher, A. & Pays, E. Human serum lyses Trypanosoma brucei by triggering uncontrolled swelling of the parasite lysosome. J. Eukaryot. Microbiol. 54, 448-451 (2007).
22. Pays, E. et al. The trypanolytic factor of human serum. Nat. Rev. Microbiol. 4, 477-486 (2006).
23. Dutoya, S. et al. A novel C-terminal kinesin is essential for maintaining functional acidocalcisomes in Trypanosoma brucei. J. Biol. Chem. 276, 49117-49124 (2001).
24. Barrera, F. N. et al. Roles of carboxyl groups in the transmembrane insertion of peptides. J. Mol. Biol. 413, 359-371 (2011).
25. Willyard, C. Putting sleeping sickness to bed. Nat. Med. 17, 14-17 (2011).
26. Raper, J. & Friedman, D. J. Parasitology: molecular one-upmanship. Nature 501, 322-323 (2013).
27. Kageruka, P. et al. Infectivity of Trypanosoma (Trypanozoon) brucei gambiense for baboons (Papio hamadryas, Papio papio). Ann. Soc. Belg. Med. Trop. 71, 39-46 (1991).
28. Cooper, A. et al. A primate APOL1 variant that kills Trypanosoma brucei gambiense. PLoS Negl. Trop. Dis. 10, e0004903 (2016).
29. Radwanska, M. et al. Novel primer sequences for a polymerase chain reaction-based detection of Trypanosoma brucei gambiense. Am. J. Trop. Med. Hyg. 67, 289-295 (2002).
30. Pyana Pati, P. et al. Melarsoprol sensitivity profile of Trypanosoma brucei gambiense isolates from cured and relapsed sleeping sickness patients from the Democratic Republic of the Congo. PLoS Negl. Trop. Dis. 8, e3212 (2014).